Digital health platform aims to tame the 'Three Highs' in massive new taipei city trial

NCT ID NCT07588256

First seen May 23, 2026 · Last updated May 23, 2026

Summary

This large study will test if a mobile digital health platform helps people better control high blood pressure, blood sugar, and cholesterol—known as the 'three highs'—to prevent heart and kidney disease. About 4,162 adults in New Taipei City will use the platform to track their health and receive guidance. The goal is to see if this approach leads to better control of these conditions compared to usual care.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HYPERTENSION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Email: •••••@•••••

Locations

  • United safety medical group(USMG)

    RECRUITING

    New Taipei City, Taiwan

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-••••

Conditions

Explore the condition pages connected to this study.